Pharmaceutical

Transcu’s transdermal drug delivery technologies are applicable in pharmaceutical and cosmeceutical solutions.

Transcu will either partner with other pharmaceutical companies for joint development or work independently to develop new drug-device products incorporating selected Active Pharmaceutical Ingredients (APIs) with Transcu’s transdermal drug delivery technologies.

For joint developments projects, Transcu will engage pharmaceutical companies in Japan, USA and Europe under a licence arrangement to jointly development these new drug-device products that will eventually be commercially sold.

For independent development projects, Transcu may either partner with generic pharmaceutical companies under a licence arrangement or work independently to develop a new generic drug-device product incorporating off-patent drugs with Transcu’s transdermal drug delivery technologies.